Drug Database
Back to search

Netherlands· NL-19d61a3ba87f

Livocab 0,5 mg/ml neusspray, suspensie

A levocabastine product containing levocabastinehydrochloride, registered in Netherlands by Kenvue Netherlands B.V.. The same ATC class is registered in 10 of our 19 countries.

ATC R01AC02

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedLivocab 0,5 mg/ml neusspray, suspensieATCR01AC02REGISTER NO.NL-19d61a3ba87fPACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about levocabastinehydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Levocabastine is registered in 10 of 19 countries.

Countries holding a registration under ATC R01AC02 (levocabastine), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 6 of them publish a price we can compare per daily dose
Search levocabastine products by name

Levocabastine · ATC R01AC02

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Japan
  • Netherlands
  • Norwayprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
LEVOCABASTINEHYDROCHLORIDE
Manufacturer
Kenvue Netherlands B.V.
Country
Netherlands (NL)
ATC code
R01AC02
ATC class
Levocabastine
Defined daily dose
0.6 mg, N
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    13967

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Levocabastine in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All levocabastine products

Authorised across Europe · EMA

The same active substance is authorised in 15 EEA countries. Names it is sold under:

  • Austria · Levocamed, Livostin
  • Belgium · Livostin, Nasasinuspray Anti-Allergie
  • Czechia · Livostin
  • Germany · Levocabastin, Levocamed
  • Denmark · Benaliv
  • Spain · Bilina, Reactine
  • Finland · Livostin
  • France · Allergiflash, Levofree
  • Greece · Livostin
  • Iceland · Livostin
  • Italy · Levoreact, Levoreact Oftalmico
  • Luxembourg · Livostin, Nasasinuspray Anti-Allergie
  • Norway · Livostin
  • Sweden · Livostin
  • Slovakia · Livostin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/2c1682ea-3f9d-4c27-94a8-5a0c0036280b
GET /v1/drugs/2c1682ea-3f9d-4c27-94a8-5a0c0036280b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Neusspray, suspensie",
  "route": "Nasaal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h13967_smpc.pdf",
  "strength": null,
  "atc_label": "Levocabastine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg13967",
  "excipients": [
    "BENZALKONIUMCHLORIDE",
    "DINATRIUMEDETAAT 2-WATER",
    "DINATRIUMWATERSTOFFOSFAAT 0-WATER (E 339)",
    "HYPROMELLOSE (E 464)",
    "NATRIUMDIWATERSTOFFOSFAAT 1-WATER (E 339)",
    "POLYSORBAAT 80 (E 433)",
    "PROPYLEENGLYCOL (E 1520)",
    "WATER, GEZUIVERD"
  ],
  "substances": [
    "LEVOCABASTINEHYDROCHLORIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h13967.pdf",
  "authorised_at": "1991/12/11",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "13967",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about levocabastine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console